Short description
Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.
Description
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies, and vaccines.
Xenetic Biosciences is formerly known as Lipoxen. Working with some of the largest pharmaceutical organizations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Framingham, Massachusetts, United States, North America
Founded on
August 1, 2011
Exited on
October 11, 2013
Went public on
October 11, 2013
Stock symbol
XBIO
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccess
Sign in for full access
Founders
Gregory Gregoriadis